You searched for eli lilly | Global Autoimmune Institute

<img alt="" src="https://secure.hiss3lark.com/178938.png" style="display:none;" />

Get Involved

Help make a difference in the lives of those with autoimmune disease.

What is Autoimmune Disease?
- AUTOIMMUNE VS AUTOINFLAMMATORY DISEASE
  
  A Comparative Look
  
  Autoimmune disease (AD) and autoinflammatory disease (AIF) are two categories of illnesses that occur when the immune system mistakenly damages healthy cells. Although these inflammatory disorders share many commonalities, there are key features that make them unique.
  Read Our Article
  Autoimmune diseases (AD) occur when the immune system attacks the body’s own healthy cells. There are 80-100 known autoimmune diseases and counting, affecting more than 14 million Americans.
  AUTOIMMUNE VS AUTOINFLAMMATORY DISEASE
  
  A Comparative Look
  
  Autoimmune disease (AD) and autoinflammatory disease (AIF) are two categories of illnesses that occur when the immune system mistakenly damages healthy cells. Although these inflammatory disorders share many commonalities, there are key features that make them unique.
  
  Read Our Article
Resources & Support
- FREE RESOURCE
  
  Find Hope in Your Health Journey
  
  The Autoimmune & Chronic Illness Toolkit includes journal templates, resource lists, guidance for doctor appointments, tips on communication, and many more tools to support and empower you throughout your experience.
  Get Our Guide
  Browse our resource lists and information via the links below.
  FREE RESOURCE
  
  Find Hope in Your Health Journey
  
  The Autoimmune & Chronic Illness Toolkit includes journal templates, resource lists, guidance for doctor appointments, tips on communication, and many more tools to support and empower you throughout your experience.
  
  Get Our Guide
Education & Research
- HIGHLIGHTED PARTNERSHIP
  
  GAI is proud to fund the Raising Celiac podcast from the Celiac Disease Program at Boston Children’s Hospital
  
  Each episode features education, awareness and research on celiac disease in connection with other autoimmune conditions, including expert interviews on how these autoimmune diseases co-exist.
  View Podcast
  We support autoimmune disease research, awareness, and education. We fund clinical research, scientific investigations, multidisciplinary medicine, and educational resources, including podcasts and webinars.
  HIGHLIGHTED PARTNERSHIP
  
  GAI is proud to fund the Raising Celiac podcast from the Celiac Disease Program at Boston Children’s Hospital
  
  Each episode features education, awareness and research on celiac disease in connection with other autoimmune conditions, including expert interviews on how these autoimmune diseases co-exist.
  
  View Podcast
About Us
- SPREADING AWARENESS
  
  We were proud to sponsor Nature Magazine’s July 2021 Outlook on Autoimmune Disease
  
  Learn more about GAI's work, autoimmune risk factors, research advances, and more!
  Read Our Feature
  The Global Autoimmune Institute is empowering solutions in the diagnosis and treatment of autoimmune disease (AD) through research, education, and validation while supporting multidisciplinary approaches to wellness.
  SPREADING AWARENESS
  
  We were proud to sponsor Nature Magazine’s July 2021 Outlook on Autoimmune Disease
  
  Learn more about GAI’s work, autoimmune risk factors, research advances, and more!
  
  Read Our Feature
Search

Search results for all "eli lilly" in COVID News & Research Updates As It Relates To Autoimmune Disease

FDA Authorizes Eli Lilly’s COVID Antibody Treatment for Children under 12

December 7, 2021 Last Friday, the FDA authorized the use of Eli Lilly’s monoclonal antibody treatment for young children, including newborns. “Monoclonal antibodies are laboratory-made proteins that mimic the immune…
NIH Funds Clinical Trial For New COVID-19 Antibody Therapy

…has previously issued emergency use authorization for COVID-19 antibody therapies by Eli Lilly and Regeneron. This new IC14 monoclonal antibody “binds to a human protein, CD14, that is found on…
FDA Authorizes Fourth Monoclonal Antibody Drug

February 15, 2022 Last Friday, the FDA authorized emergency use of Eli Lilly’s monoclonal antibody treatment, bebtelovimab, for treating mild-to-moderate COVID-19. Bebtelovimab has been shown to be highly effective against…
Monoclonal Antibody Treatment Authorized for Immunocompromised Persons

…antibody treatments, such as Eli Lilly’s or Merck’s, in that it is administered as a long-acting prophylactic (disease preventative) as opposed to being a treatment for those already infected by…

1 2 >>